We are live on ! Find out more
CCM

Cupps Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 49.73%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+49.73%
3 Year Est. Return
+212.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$156M
Cap. Flow
-$194M
Cap. Flow %
-83.99%
Top 10 Hldgs %
24.21%
Holding
206
New
45
Increased
20
Reduced
112
Closed
29

Top Buys

Rank Stock Value
1
MDSO
Medidata Solutions, Inc.
MDSO
+$2.5M
2
GKOS icon
Glaukos
GKOS
+$2.17M
3
TSRO
TESARO, Inc.
TSRO
+$1.61M
4
CAVM
Cavium, Inc.
CAVM
+$1.52M
5
BLUE
bluebird bio
BLUE
+$1.51M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$9.12M
2
NVRO
NEVRO CORP.
NVRO
+$8.36M
3
AMZN icon
Amazon
AMZN
+$7.51M
4
BURL icon
Burlington
BURL
+$6.63M
5
TXRH icon
Texas Roadhouse
TXRH
+$5.36M

Sector Composition

Rank Sector Weight
1 Technology 41.04%
2 Healthcare 24.89%
3 Consumer Discretionary 10.15%
4 Industrials 9.46%
5 Real Estate 3.33%

No holdings matched the selected filter criteria.

5 6 7 8 9

Similar funds

SA
Smithwood Advisers Los Angeles, California $241M AUM 16.29% 1-Year Est. Return
WIM
Wingspan Investment Management New York $215M AUM 30.25% 1-Year Est. Return
EDRE
Edmond de Rothschild (Europe) Luxembourg $248M AUM 20.4% 1-Year Est. Return
RIG
Raveneur Investment Group New York $254M AUM 28.8% 1-Year Est. Return
VBCP
Vollero Beach Capital Partners New York $255M AUM 50.09% 1-Year Est. Return
TI
Tyrian Investments New York $260M AUM 1.94% 1-Year Est. Return
ZBI
Ziff Brothers Investments New York $267M AUM 49.36% 1-Year Est. Return
MI
Montage Investments Leawood, Kansas $182M AUM 18.14% 1-Year Est. Return

Cupps Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Cupps Capital Management held 206 positions worth $231M, down 40% from $387M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Cupps Capital Management withdrew a net $194M in Q3 2016, closing 29 positions and reducing 112 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.68M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Cupps Capital Management opened a new position in Medidata Solutions, Inc. worth $2.63M.

  • Cupps Capital Management's largest Q3 2016 buy was Medidata Solutions, Inc.: 47,254 shares worth $2.63M.
  • Cupps Capital Management added most to Cavium, Inc. in Q3 2016, an estimated $1.52M increase.
  • Cupps Capital Management's biggest Q3 2016 reduction was Abiomed Inc, cutting an estimated $9.12M.
  • Cupps Capital Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $3.68M.
  • Cupps Capital Management's ten largest holdings make up 24% of its $231M portfolio in Q3 2016.
  • Cupps Capital Management opened 45 new positions and closed 29 in Q3 2016.
  • Cupps Capital Management's portfolio value fell 40% quarter-over-quarter to $231M.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.